Articles & Video
Sponsors running multi country trials must guard against bribery
Globalization of drug research has increased the likelihood of bribery according to new analysis, which suggests the risk is greatest for international, multi-center trials.
Parexel partners in Japan for decentralized trials and regenerative meds
Parexel has teamed with Kyoto University Hospital in Japan to promote novel trial approaches and tap demand for cell and gene therapy studies.
Pacific Cancer Care to use AI to find trial patients in Deep Lens deal
The Pacific Cancer Care has teamed with patient recruitment specialist Deep Lens to use artificial intelligence technologies to expand its clinical trial programs.
Icon and Informa team on AI-based study feasibility technology
Icon has tapped industry study data to train the artificial intelligence (AI) based clinical trial feasibility service being developed with Informa Pharma Intelligence.
Shift to remote trials accelerating but new hurdles emerging
Most sponsors and CROs are using decentralized trial technology but more data management work needs to be done to take full advantage of the approach according to new research.
Decentalized trials ideal for Australia say ObvioHealth and Anatara
Anatara Lifesciences has hired “virtual” research organization ObvioHealth Partners for what the firms claim is a first of its kind hybrid clinical trial.
Syneos buys RxDataScience citing trials and product lifecycle business
Syneos Health has bought artificial intelligence and analytics firm RxDataScience with decentralized trials and product lifecycles services in mind.
FDA raises concerns about two Indian CROS, calls for study repetition
The US FDA wants several drug firms to repeat studies over concerns about data generated by CROs Synchron Research Services and Panexcell Clinical Lab.
Emmes: Demand for COVID-19 trial service will continue
Emmes predicts demand for COVID-19 related trials and development work will continue as industry seeks to develop treatments for emerging viral variants.
Lilly expands Care Access partnership to boost diversity
Eli Lilly has expanded its partnership with Care Access to diversity its pool of participants for clinical trials.
Curavit joins decentralized trials group, predicts demand will keep growing
Curavit has joined the Decentralized Trials & Research Alliance, an industry-backed non-profit organization focused on the promotion of remote studies.
Icon gets €4m from Ireland to build decentralized trial business
The Irish Government has given Icon €4m to boost its decentralized clinical trial and technology business.
Velocity buys VitaLink and NRI to expand US site network
Velocity Clinical Research has bought VitaLink Research and the National Research Institute expanding its network of US trial sites.
Backers stump-up €135m to fund Elligo’s ClinEdge acquisition
Investors have backed Elligo Health Research to the tune of €135 million ($158 million) in a funding round announced this week.
Thread launches decentralized trial consulting service
Decentralized trials are here to stay according to tech firm Thread, which has set up a consulting service to help drug developers make best use of the approach.
Labcorp selects Medidata tech to expand clinical trial capabilities
Medidata will process medical-grade sensor data across Labcorp’s clinical trial portfolio, bolstering their decentralized clinical trial offerings.
Syneos buys StudyKIK in latest move to grow decentralized trials business
Syneos Health has acquired clinical trial recruitment firm StudyKIK, citing its recruitment and retention technologies as the driver.
WCG combines Avoca and MCC citing benefits of collaboration
WCG has combined recent acquisition the Avoca Quality Consortium with the Metrics Champion Consortium (MCC), its clinical trial metrics operation.
Health Catalyst aims to help drug firms and CROs find trial participants
Health Catalyst has launched a service to help drug firms and CROs to make the most of the clinical databases.
Looking to the Future of Clinical Trials | Clinical Trials eBook Series
With COVID-19 and ever changing technology, we look at the future of clinical trials in the Informa Connect Clinical Trials eBook Series.